ALPA, Mirella
ALPA, Mirella
A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance Therapy
2021-01-01 Roccatello D.; Sciascia S.; Naretto C.; Alpa M.; Fenoglio R.; Ferro M.; Quattrocchio G.; Rubini E.; Rahbani E.; Rossi D.
An agent-to-agent real life comparison study of tocilizumab versus abatacept in giant cell arteritis
2021-01-01 Rossi, Daniela; Cecchi, Irene; Sciascia, Savino; Naretto, Carla; Alpa, Mirella; Roccatello, Dario
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation
2020-01-01 Fenoglio R.; Baldovino S.; Ferro M.; Sciascia S.; Rabajoli G.; Quattrocchio G.; Beltrame G.; Naretto C.; Rossi D.; Alpa M.; Barreca A.; Papotti M.G.; Roccatello D.
Renal involvement as a unique manifestation of hemophagocytic syndrome
2022-01-01 Roccatello, Dario; Sciascia, Savino; Barreca, Antonella; Naretto, Carla; Alpa, Mirella; Quattrocchio, Giacomo; Radin, Massimo; Fenoglio, Roberta
The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study
2017-01-01 Roccatello, Dario; Sciascia, Savino; Rossi, Daniela; Alpa, Mirella; Naretto, Carla; Radin, Massimo; Fenoglio, Roberta; Baldovino, Simone; Menegatti, Elisa
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance Therapy | 2021 | Roccatello D.; Sciascia S.; Naretto C.; Alpa M.; Fenoglio R.; Ferro M.; Quattrocchio G.; Rubini E.; Rahbani E.; Rossi D. | |
| An agent-to-agent real life comparison study of tocilizumab versus abatacept in giant cell arteritis | 2021 | Rossi, Daniela; Cecchi, Irene; Sciascia, Savino; Naretto, Carla; Alpa, Mirella; Roccatello, Dario | |
| Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation | 2020 | Fenoglio R.; Baldovino S.; Ferro M.; Sciascia S.; Rabajoli G.; Quattrocchio G.; Beltrame G.; Naretto C.; Rossi D.; Alpa M.; Barreca A.; Papotti M.G.; Roccatello D. | |
| Renal involvement as a unique manifestation of hemophagocytic syndrome | 2022 | Roccatello, Dario; Sciascia, Savino; Barreca, Antonella; Naretto, Carla; Alpa, Mirella; Quattrocchio, Giacomo; Radin, Massimo; Fenoglio, Roberta | |
| The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study | 2017 | Roccatello, Dario; Sciascia, Savino; Rossi, Daniela; Alpa, Mirella; Naretto, Carla; Radin, Massimo; Fenoglio, Roberta; Baldovino, Simone; Menegatti, Elisa |